Cardiology MCQ
The PCSK9 inhibitor which was recently approved by FDA:
a) Evolocumab
b) Alirocumab
c) Infliximab
d) Abciximab
Read More
General Cardiology
Familial hypercholesterolemia Familial hypercholesterolemia is an autosomal dominant disorder and should be suspected when the total cholesterol levels are above 300 mg/dL in adults and above 250 mg/dL
Read More